Stay updated on Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Sign up to get notified when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    Change Detected
    Summary
    The site footer’s revision label changed from v3.7.2 to v3.8.0; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-11-02T16:19:08.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears on the page.
    Difference
    0.7%
    Check dated 2026-10-26T14:49:19.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov site footer revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-19T14:27:50.000Z thumbnail image
  5. Check
    33 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision changed from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-12T14:40:15.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    The study record history adds a new revision entry (v3.7.0). The previous revision (v3.6.6) is removed from the list, reflecting an update to the page's version history.
    Difference
    0.1%
    Check dated 2026-09-21T20:12:56.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    A new Revision: v3.6.6 is added to the history and the previous Revision: v3.6.5 is removed. This reflects a minor update to the page's revision logs rather than any change to study content or user-facing features.
    Difference
    0.1%
    Check dated 2026-08-31T17:47:47.000Z thumbnail image

Stay in the know with updates to Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Diarrhea in HER2+ Breast Cancer: Trastuzumab/Neratinib Clinical Trial page.